L San

Summary

Country: Spain

Publications

  1. ncbi Pharmacological management of acutely agitated schizophrenic patients
    L San
    Hospital de San Rafael, Passeig Vall d Hebron 107 117, 08035 Barcelona, Spain
    Curr Pharm Des 11:2471-7. 2005
  2. ncbi A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients
    L San
    Hospital San Rafael, Passeig Vall d Hebron, 107 117, 08035 Barcelona, Spain
    Eur Psychiatry 21:539-43. 2006
  3. ncbi Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders
    Luis San
    Department of Psychiatry, Hospital San Rafael, Barcelona, Spain
    Eur Addict Res 13:230-43. 2007
  4. ncbi Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study
    Luis San
    Hospital San Rafael, Barcelona, Spain
    Eur Psychiatry 22:490-8. 2007
  5. doi Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis
    B Arranz
    Sant Joan de Deu, Serveis de Salut Mental, Sant Boi de Llobregat, Barcelona, Spain
    Acta Psychiatr Scand 119:71-7. 2009
  6. ncbi Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients
    Belen Arranz
    Benito Menni, Mental Health Care Institute, Antoni Pujadas 38, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Psychiatry Res 118:165-74. 2003
  7. ncbi [Instruments of depression assessment in schizophrenia]
    N Ramirez
    Servicio de Psiquiatría Hospital General de Granollers, Barcelona, Spain
    Actas Esp Psiquiatr 29:259-68. 2001
  8. doi Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission
    Julio Bobes
    Department of Psychiatry, School of Medicine, University of Oviedo, Center for Networked Biomedical Research on Mental Health CiberSam, Oviedo, Spain
    Schizophr Res 115:58-66. 2009
  9. ncbi Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients
    B Arranz
    Hospital San Rafael, Barcelona, Spain
    Hum Psychopharmacol 22:11-5. 2007
  10. ncbi [Rhabdomyolysis due to polydipsia in a patient with psychotic disorder]
    N Ramirez
    Servicio de Psiquiatria, Hospital General de Granollers, Benito Menni, Complejo Assistencial en Salud Mental, Barcelon
    Actas Esp Psiquiatr 32:56-9. 2004

Collaborators

Detail Information

Publications26

  1. ncbi Pharmacological management of acutely agitated schizophrenic patients
    L San
    Hospital de San Rafael, Passeig Vall d Hebron 107 117, 08035 Barcelona, Spain
    Curr Pharm Des 11:2471-7. 2005
    ..Therefore, they should be considered as first line therapy in agitated schizophrenic patients...
  2. ncbi A naturalistic multicenter study of intramuscular olanzapine in the treatment of acutely agitated manic or schizophrenic patients
    L San
    Hospital San Rafael, Passeig Vall d Hebron, 107 117, 08035 Barcelona, Spain
    Eur Psychiatry 21:539-43. 2006
    ..The data thus obtained was compared with that reported from randomized double-blind clinical trials...
  3. ncbi Antipsychotic drug treatment of schizophrenic patients with substance abuse disorders
    Luis San
    Department of Psychiatry, Hospital San Rafael, Barcelona, Spain
    Eur Addict Res 13:230-43. 2007
    ....
  4. ncbi Symptomatic remission and social/vocational functioning in outpatients with schizophrenia: prevalence and associations in a cross-sectional study
    Luis San
    Hospital San Rafael, Barcelona, Spain
    Eur Psychiatry 22:490-8. 2007
    ..We aimed to know the prevalence and clinical features of patients with schizophrenia achieving these outcomes...
  5. doi Clinical and serotonergic predictors of non-affective acute remitting psychosis in patients with a first-episode psychosis
    B Arranz
    Sant Joan de Deu, Serveis de Salut Mental, Sant Boi de Llobregat, Barcelona, Spain
    Acta Psychiatr Scand 119:71-7. 2009
    ..The study aimed to establish clinical predictors of non-affective acute remitting psychosis (NARP) and assess whether these patients showed a distinct serotonergic profile...
  6. ncbi Altered platelet serotonin 5-HT2A receptor density but not second messenger inositol trisphosphate levels in drug-free schizophrenic patients
    Belen Arranz
    Benito Menni, Mental Health Care Institute, Antoni Pujadas 38, 08830 Sant Boi de Llobregat, Barcelona, Spain
    Psychiatry Res 118:165-74. 2003
    ..posttreatment values. These results are possibly related to failure of second messenger systems of 'translating' extracellular messages generated presynaptically into effective neurotransmitter signals in schizophrenic patients...
  7. ncbi [Instruments of depression assessment in schizophrenia]
    N Ramirez
    Servicio de Psiquiatría Hospital General de Granollers, Barcelona, Spain
    Actas Esp Psiquiatr 29:259-68. 2001
    ..The present paper reviews the instruments used so far on the assessment of depressive symptomatology in schizophrenic patients...
  8. doi Recovery from schizophrenia: results from a 1-year follow-up observational study of patients in symptomatic remission
    Julio Bobes
    Department of Psychiatry, School of Medicine, University of Oviedo, Center for Networked Biomedical Research on Mental Health CiberSam, Oviedo, Spain
    Schizophr Res 115:58-66. 2009
    ..This report presents the results of an observational empirical clinical investigation about the prevalence and correlates of a proposed definition of recovery from schizophrenia in outpatients in Spain...
  9. ncbi Lower weight gain with the orally disintegrating olanzapine than with standard tablets in first-episode never treated psychotic patients
    B Arranz
    Hospital San Rafael, Barcelona, Spain
    Hum Psychopharmacol 22:11-5. 2007
    ..orally disintegrating formulation)...
  10. ncbi [Rhabdomyolysis due to polydipsia in a patient with psychotic disorder]
    N Ramirez
    Servicio de Psiquiatria, Hospital General de Granollers, Benito Menni, Complejo Assistencial en Salud Mental, Barcelon
    Actas Esp Psiquiatr 32:56-9. 2004
    ..It is considered necessary to keep in mind the in mind the diagnosis of polydipsia in any psychiatric patient showing acute symptoms of confusion...
  11. ncbi [Cannabis dependence: clinical implications. Based and one case]
    P Fernandez Corcuera
    CASM Benito Menni, Sant Boi de Llobregat, Barcelona, Spain
    Actas Esp Psiquiatr 31:299-301. 2003
    ..The adverse effects include affective and eating disorders, and the possibility of seizure induction. A novel therapeutic strategy in cannabis dependence is reported. Key words: Cannabis. Mania. Bulimic behaviors...
  12. ncbi [Course and prognosis of a case of central pontine myelinolysis in eating behavior disorder]
    N Ramirez
    Servicio de Psiquiatria, Hospital San Rafael, P Valle Hebron 107 117, 08025 Barcelona
    Actas Esp Psiquiatr 35:141-4. 2007
    ..Close monitoring of the clinical symptoms and neuroimaging findings should be carried out in these patients during the first months...
  13. doi Predictors of schizophrenia in patients with a first episode of psychosis
    Nicolas Ramirez
    Department of Psychiatry, Hospital San Rafael, Barcelona, Spain
    Psychiatry Res 175:11-4. 2010
    ..The regression model including these three variables achieved a predictive value of 76.3%, with a sensitivity of 74.6% and a specificity of 77.9%...
  14. ncbi Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients
    Belen Arranz
    Department of Psychiatry, Benito Menni, Mental Health Care Institute, Hospital de Granollers, Barcelona, Spain
    J Clin Psychiatry 65:1335-42. 2004
    ....
  15. ncbi Different distributions of the 5-HT reuptake complex and the postsynaptic 5-HT(2A) receptors in Brodmann areas and brain hemispheres
    Pilar Rosel
    Hormone and Genetic Unit, Department of Clinical Chemistry, CSUB Hospital Princeps d Espanya, Feixa Llarga s n, 08907 Barcelona, Spain
    Psychiatry Res 111:105-15. 2002
    ..These results suggest the need to carefully define the brain hemisphere and the Brodmann areas studied, as well to avoid comparisons between studies including different Brodmann areas or brain hemispheres...
  16. ncbi Combined use of platelet serotonergic markers and psychopathological scales as diagnostic screening of a psychotic versus a depressive disorder
    Nicolas Ramirez
    Benito Menni, CASM, Hospital de Granollers, Mental Health Care Institute, Avda Francesc Ribas s n, 08400 Granollers, Barcelona, Spain
    Eur Psychiatry 18:369-71. 2003
    ..The results suggest the need of performing further studies combining biological and clinical markers of psychiatric disorders...
  17. ncbi Cross-cultural adaptation and validation of the Spanish version of the Calgary Depression Scale for Schizophrenia
    Salvador Sarró
    Department of Psychiatry, Hospital General de Granollers, Avda Francesc Ribas s n, E 08400, Granollers, Barcelona, Spain
    Schizophr Res 68:349-56. 2004
    ..Therefore, it may be predicted that a Spanish version of this scale will be also a valid instrument to assess symptoms of depression in patients with schizophrenia...
  18. ncbi Altered 5-HT2A and 5-HT4 postsynaptic receptors and their intracellular signalling systems IP3 and cAMP in brains from depressed violent suicide victims
    Pilar Rosel
    Hormone Unit, Department of Biochemistry, CSU Bellvitge, Barcelona, Spain
    Neuropsychobiology 49:189-95. 2004
    ..Further studies on suicidality and depression should focus on the functionality of the caudate nucleus...
  19. ncbi Low baseline serotonin-2A receptors predict clinical response to olanzapine in first-episode schizophrenia patients
    Belen Arranz
    Department of Psychiatry, Hospital San Rafael, and Department of Clinical Chemistry, Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona, Spain
    Psychiatry Res 153:103-9. 2007
    ..The reported results suggest that platelet 5-HT2A binding might be a trait marker that could help to identify those patients likely to show greater improvement in negative symptomatology after olanzapine treatment...
  20. doi Olanzapine orally disintegrating tablet: a review of efficacy and compliance
    Luis San
    Servicio de Psiquiatria, Hospital San Igualada, Barcelona, Spain
    CNS Neurosci Ther 14:203-14. 2008
    ..This is especially important in diseases such as schizophrenia and bipolar disorder, which can be chronic and require long-term treatment...
  21. ncbi Polymorphisms of the 5-HT2C receptor and leptin genes are associated with antipsychotic drug-induced weight gain in Caucasian subjects with a first-episode psychosis
    Lucy A Templeman
    Division of Psychiatry and Neuroscience, Queen s University Belfast, Whitla Medical Building, 97 Lisburn Road, Belfast BT9 7BL, UK
    Pharmacogenet Genomics 15:195-200. 2005
    ..We have investigated whether these effects remain true in a Caucasian population and following longer term treatment...
  22. ncbi What do we know about insulin resistance and glucose metabolism in patients with schizophrenia treated with antipsychotics?
    Belen Arranz
    J Clin Psychiatry 68:800-1; author reply 801-2. 2007
  23. ncbi Practical application of pharmacotherapy with long-acting risperidone for patients with schizophrenia
    Samuel J Keith
    Department of Psychiatry, University of New Mexico, Albuquerque 87131 1161, USA
    Psychiatr Serv 55:997-1005. 2004
    ..This article provides practical advice to physicians on the characteristics of patients who would benefit from treatment with long-acting atypical antipsychotic agents and offers suggestions on how to initiate treatment...
  24. ncbi Effect of 5-HT1A receptor gene polymorphism on negative and depressive symptom response to antipsychotic treatment of drug-naive psychotic patients
    Gavin P Reynolds
    Division of Psychiatry and Neuroscience, Queen s University Belfast, Whitla Medical Building, 97 Lisburn Rd, Belfast BT9 7BL UK
    Am J Psychiatry 163:1826-9. 2006
    ..The authors sought to determine whether this polymorphism influences symptom response to antipsychotic drug treatment...
  25. ncbi Reboxetine adjunct for partial or nonresponders to antidepressant treatment
    Gabriel Rubio
    Psychiatry Service, La Paz University Hospital, Madrid, Spain
    J Affect Disord 81:67-72. 2004
    ..To investigate the usefulness of the combination therapy with two antidepressants from different pharmacological families in treatment-resistant depressive patients...
  26. ncbi [Post-traumatic stress disorder and substance use disorder: treatment intervention]
    Jose Martinez Raga
    Psiquiatra, Instituto de Drogas y Conductas Adictivas, Universidad Cardenal Herrera, CEU y Agencia Valenciana de Salud, Espana
    Vertex 16:412-7. 2005
    ..In addition, pharmacological options, among them quetiapine or bupropion have shown promising results in preliminary studies...